NCT06105684View on ClinicalTrials.gov

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Capecitabine Pill

Will be given once per day by mouth

Trial Locations (1)

35294

RECRUITING

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER